Stay updated on rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial
Sign up to get notified when there's something new on the rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial page.

Latest updates to the rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier updates from v3.8.0 to v3.8.1, while the study record content remains unchanged.SummaryDifference0.1%

- Check12 days agoChange DetectedThe HORIZON study record is now displayed, describing a Phase 1/2 gene-therapy trial for X-linked retinitis pigmentosa, its participant criteria and study design, and its locations and measures. The record also includes study dates, sponsor information, and related publications.SummaryDifference49%

- Check19 days agoChange DetectedThe ClinicalTrials.gov site revision shown in the footer changed from v3.7.2 to v3.8.0, while the study record remains inaccessible.SummaryDifference0.2%

- Check33 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study content remains inaccessible behind a 403 error.SummaryDifference1%

- Check47 days agoChange DetectedThe ClinicalTrials.gov page footer now shows revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now shows a 403 Forbidden error message with the standard header and footer, and the usual study details are not displayed due to access restrictions.SummaryDifference18%

Stay in the know with updates to rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial page.